Payden & Rygel’s Ares Capital ARCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.11M Buy
275,660
+274,500
+23,664% +$5.12M 0.39% 70
2026
Q1
$21K Hold
1,160
﹤0.01% 110
2025
Q4
$23K Hold
1,160
﹤0.01% 113
2025
Q3
$24K Hold
1,160
﹤0.01% 112
2025
Q2
$25K Hold
1,160
﹤0.01% 110
2025
Q1
$26K Hold
1,160
﹤0.01% 122
2024
Q4
$25K Hold
1,160
﹤0.01% 121
2024
Q3
$24K Hold
1,160
﹤0.01% 120
2024
Q2
$24K Hold
1,160
﹤0.01% 120
2024
Q1
$24K Hold
1,160
﹤0.01% 133
2023
Q4
$23K Hold
1,160
﹤0.01% 134
2023
Q3
$23K Hold
1,160
﹤0.01% 133
2023
Q2
$22K Hold
1,160
﹤0.01% 131
2023
Q1
$21K Sell
1,160
-10,100
-90% -$191K ﹤0.01% 121
2022
Q4
$208K Sell
11,260
-873,580
-99% -$16.4M 0.01% 121
2022
Q3
$14.9M Hold
884,840
0.87% 56
2022
Q2
$15.9M Sell
884,840
-40,100
-4% -$790K 0.95% 53
2022
Q1
$19.4M Sell
924,940
-2,500
-0.3% -$53.3K 0.98% 61
2021
Q4
$19.7M Buy
927,440
+400
+0% +$8.31K 0.91% 62
2021
Q3
$18.8M Buy
+927,040
New +$18.6M 0.98% 64

Other funds holding ARCC

Payden & Rygel's ARCC Position: Q2 2026 in Review

Payden & Rygel increased its Ares Capital (ARCC) stake by 23,664% in Q2 2026, buying an estimated $5.12M and bringing the position to 275,660 shares worth $5.11M. The position accounts for 0.39% of the portfolio, ranked #70.

Payden & Rygel first reported a position in ARCC in Q3 2021 and has held it in 20 quarters since. The position peaked at $19.7M in Q4 2021. 785 funds tracked by Wall St. Rank hold ARCC as of Q2 2026.

  • Payden & Rygel held 275,660 shares of Ares Capital worth $5.11M as of Q2 2026.
  • Payden & Rygel bought 274,500 Ares Capital shares in Q2 2026, an estimated $5.12M.
  • Ares Capital made up 0.39% of Payden & Rygel's portfolio in Q2 2026, its #70 holding.
  • Payden & Rygel first reported a position in Ares Capital in Q3 2021 and has held it in 20 quarters since.
  • Payden & Rygel's Ares Capital position peaked at $19.7M in Q4 2021.
  • 785 funds tracked by Wall St. Rank held Ares Capital as of Q2 2026.

Based on Payden & Rygel's 13F filing for Q2 2026, filed 31 Jul 2026.